WO2017206380A1 - 调血脂仪器及其使用的光源材料 - Google Patents

调血脂仪器及其使用的光源材料 Download PDF

Info

Publication number
WO2017206380A1
WO2017206380A1 PCT/CN2016/097274 CN2016097274W WO2017206380A1 WO 2017206380 A1 WO2017206380 A1 WO 2017206380A1 CN 2016097274 W CN2016097274 W CN 2016097274W WO 2017206380 A1 WO2017206380 A1 WO 2017206380A1
Authority
WO
WIPO (PCT)
Prior art keywords
phosphor
light source
source material
column portion
lipid regulating
Prior art date
Application number
PCT/CN2016/097274
Other languages
English (en)
French (fr)
Inventor
孙德春
李志才
袁世江
Original Assignee
长春先盈医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 长春先盈医疗科技有限公司 filed Critical 长春先盈医疗科技有限公司
Publication of WO2017206380A1 publication Critical patent/WO2017206380A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/64—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing aluminium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7706—Aluminates
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7712—Borates
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • C09K11/7766—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals
    • C09K11/778—Borates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0614—Tanning
    • A61N2005/0615—Tanning using UV light sources having a specific spectrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light

Definitions

  • the invention relates to the field of medical technology, in particular to a blood lipid regulating device and a light source material used therefor.
  • dyslipidemia is a relatively common type of disease, which is a metabolic abnormality of lipoproteins in humans, including total cholesterol and low-density lipoprotein cholesterol, elevated triglycerides, and/or high-density lipoprotein reduction.
  • atherosclerosis is also an independent risk factor for coronary heart disease and ischemic stroke.
  • one of the objects of the present invention is to provide a light source material having high luminous efficiency, low light attenuation, and strong chemical stability.
  • Another object of the present invention is to provide a light source with a simple and compact structure.
  • a lipid-regulating device based on materials that can effectively prevent and treat dyslipidemia and related diseases caused by dyslipidemia.
  • a light source material comprising a phosphor composed of 0.1-100.0 ultraviolet phosphor and 0.0-99.9 visible phosphor according to a mass percentage, wherein the ultraviolet phosphor is composed of an A phosphor or B phosphor composition or a combination of A phosphor and B phosphor;
  • the chemical expression of the A phosphor is M 1-xy ⁇ Al 11 O 19 : Cd x R y
  • the chemical expression of the B phosphor is M 1-xyz La y Mg z ⁇ B 3 O 7 : Pb x ; wherein 0.001 ⁇ x ⁇ 0.1, 0.001 ⁇ y ⁇ 0.5, 0.001 ⁇ z ⁇ 0.5
  • M is an element of yttrium, calcium, magnesium, strontium, zinc or a combination of various elements
  • R is ⁇ , ⁇ An element or combination of elements of ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ .
  • the peak range of the emission spectrum of the A phosphor excited by ultraviolet light having a wavelength of 254 nm is 307 ⁇ 5 nm.
  • the peak range of the emission spectrum of the B phosphor excited by ultraviolet light having a wavelength of 254 nm is 297 ⁇ 5 nm.
  • the invention relates to a blood regulating lipid device, which comprises a vertical body, a bottom surface of the vertical body is formed to extend forwardly to form a stepped seat, and a top of the vertical body is provided with a quantum generator distributed in parallel with the step seat.
  • a quantum generator distributed in parallel with the step seat.
  • an energy detector having an emission spectrum peak range of 297-450 nm is installed, and the quantum generator includes an auxiliary light source and fluorescence.
  • the light source material of the fluorescent light source adopts a light source material as described above, and the auxiliary light source is one or a combination of any one of a fluorescent lamp, an LED lamp, and a semiconductor defocused laser lamp.
  • the emission spectrum of the auxiliary light source ranges from 610 nm to 800 nm.
  • the fluorescent light source further comprises a lamp housing having a straight tube shape, a curved tube shape, a spherical shape or an ellipsoid shape, and the lamp housing is made of borosilicate glass.
  • the vertical body comprises a column portion and a slab mounted below the rear side wall of the column portion, the step is formed at a bottom front end of the column portion, and the energy detector is installed in the column portion a middle portion of the front side wall, wherein the column portion is provided with a lifting drive controlled by the collecting station and connected to the quantum generator, and the lifting driver drives the quantum generator to perform an up-and-down feeding motion with respect to the column portion, the energy
  • the detector and the quantum generator are respectively electrically connected to the control console and controlled by the control console.
  • the bottom surface of the step seat is provided with two symmetrically distributed front casters
  • the bottom surface of the control console is provided with two symmetrically distributed rear casters and a ground brake between the two rear casters.
  • the set console also forms a pusher.
  • the invention can form a fluorescent light source with high luminous efficiency, small light decay, good chemical stability and the like, and simulates biological light
  • the fluorescent light source can adopt light irradiation method and utilize the principles of biomedicine and photonics.
  • the light source material can emit visible light, defocused laser and healthy waveform of UV-B segment; and the amount of light released by the blood lipid regulating device formed by the light source material
  • the blood lipid regulating device After being selectively absorbed by blood lipids, it promotes biochemical reactions of blood lipids in the human body, and utilizes the inherent lipid metabolism pathways of the human body.
  • Cholesterol, triglycerides, etc. are metabolized by the human body, thereby effectively preventing and treating dyslipidemia and the related The disease; and the blood lipid regulating device has the characteristics of simple and compact structure, convenient use and remarkable therapeutic effect.
  • Figure 1 is a schematic view of the overall structure of the embodiment of the present invention (1);
  • FIG. 2 is a schematic view of the overall structure of the embodiment of the present invention (2);
  • FIG. 3 is a schematic exploded view of the structure of the embodiment of the present invention.
  • FIG. 4 is a schematic structural view of a quantum generator according to an embodiment of the present invention.
  • a fluorescent light source comprising a phosphor, wherein the phosphor is composed of 0.1-100.0 ultraviolet phosphor and 0.0-99.9 visible phosphor, wherein the ultraviolet phosphor is A.
  • the phosphor is composed of either a B phosphor or a combination of an A phosphor and a B phosphor; the chemical expression of the A phosphor is M 1-xy ⁇ Al 11 O 19 : Cd x R y , and the phosphor of the B phosphor The expression is M 1-xyz La y Mg z ⁇ B 3 O 7 : Pb x ; wherein 0.001 ⁇ x ⁇ 0.1, 0.001 ⁇ y ⁇ 0.5, 0.001 ⁇ z ⁇ 0.5, M is strontium (Sr), calcium (Ca , ⁇ (Ba), zinc (Zn), or a combination of elements, R is bismuth (Bi), strontium (Sc), strontium (Y
  • a fluorescent light source having high luminous efficiency, small light decay, and good chemical stability can be formed, which can be irradiated with light.
  • the method uses the principles of biomedicine and photonics to illuminate the human body. Because the light source material can emit visible light, defocused laser and healthy waveform of UV-B segment, it can effectively prevent and treat dyslipidemia and related diseases. It plays a vital role in enhancing the resistance of human diseases and maintaining human health.
  • the peak range of the emission spectrum of the A phosphor of the present embodiment excited by ultraviolet light having a wavelength of 254 nm is preferably 307 ⁇ 5 nm.
  • the peak range of the emission spectrum of the B phosphor excited by ultraviolet light having a wavelength of 254 nm is preferably 297 ⁇ 5 nm.
  • the present invention further provides a blood lipid regulating device, which comprises a vertical body, and a step 1 is formed on the bottom surface of the vertical body to extend forward.
  • the top of the body is provided with a quantum generator 2 distributed in parallel with the step 1.
  • a peak range of the emission spectrum is disposed between the step 1 and the quantum generator 2.
  • the energy detector 3 between 297 and 450 nm, the quantum generator 2 comprises an auxiliary light source a and a fluorescent light source b, wherein the light source material of the fluorescent light source b is a light source material as described above, and the auxiliary light source a is based on a specific situation.
  • One or a combination of one or more of a fluorescent lamp, an LED lamp (having an emission spectrum peak of 297-800 nm), and a semiconductor defocused laser lamp (having a defocus laser having a peak emission of 650 nm) is selected.
  • the fluorescent light source b and the auxiliary light source a are used to form a biological light source (ie, the quantum generator 2) of the blood lipid regulating device, and the patient is irradiated to the human body by the quantum generator 2 after standing on the instrument by the stepping body 1 by the vertical body 2,
  • the photon generated by the quantum generator 2 is absorbed by the blood lipid correspondingly, promotes the biochemical reaction of the human blood lipids, utilizes the inherent metabolic lipid pathway of the human body, and cholesterol, triglyceride, etc.
  • energy detector 3 can be used to monitor the illumination energy irradiated on the human body in real time, which is convenient for The light intensity is adjusted in real time.
  • the emission spectrum of the auxiliary light source a of the present embodiment preferably ranges from 610 nm to 800 nm.
  • the fluorescent light source b of the embodiment further comprises a lamp shell (not shown) having a straight tubular shape, a curved tube shape, a spherical shape or an ellipsoid shape, and the lamp shell is made of high boron. Silicon glass In this way, the high-boron glass is used to transmit the UV-B segment light and visible light while simultaneously cutting off the UV-C segment light to ensure the transparency of the healthy waveform.
  • the vertical body of the present embodiment includes a column portion 4 and a center console 5 installed under the rear side wall of the column portion 4 (its
  • the utility model is mainly composed of an outer casing, a driving plate packaged in the outer casing and a touch operation screen embedded on the outer casing.
  • the step 1 is formed at the bottom front end of the column portion 4, and the energy detector 3 is installed on the column portion 4.
  • a lifting drive 6 (which is mainly composed of a hydraulic actuator and a guide rail) controlled by the center console 5 and connected to the quantum generator 2 is mounted in the column portion 4, and the lifting driver 6 drives the quantum.
  • the generator 2 is moved up and down with respect to the column portion 4, and the energy detector 3 and the quantum generator 2 are electrically connected to the center console 5 and controlled by the center console 5, respectively.
  • the control console 5 can be used as an operation terminal of the entire instrument to realize the control of the function of the instrument, and the power provided by the elevation drive 6 can adjust the position of the quantum generator 2 according to the individual condition of the patient to provide the patient with the position. Sufficient standing space for the quantum generator 2 to illuminate the human body.
  • two symmetrically distributed front casters 7 are mounted on the bottom surface of the step 1, and two symmetrically distributed rear casters 8 and one are placed on the bottom surface of the control console 5 a grounding device 9 between the two rear casters 8 (which can raise the instrument to ensure that the corresponding casters are disengaged from the bottom surface, thereby preventing the instrument from moving at will), and at the same time, a pusher 10 is formed on the center console 5 for the operator to push instrument.
  • a blood lipid regulating device may adopt the following method, and the method comprises the following steps:
  • the human body is irradiated by the quantum generator 2; wherein the light output power of the quantum generator 2 (ie, the total irradiation dose) is no more than 10 ⁇ w/cm 2 /min to 200 ⁇ w per day.
  • the cm 2 /min, the light output power of the mobile module (ie, the total irradiation dose) is no more than 10 ⁇ w/cm 2 /min to 200 ⁇ w/cm 2 /min cumulative per day.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

一种调血脂仪器及其使用的光源材料。光源材料包括荧光粉，按质量百分比，荧光粉由0.1-100.0的紫外光荧光体和0.0-99.9的可见光荧光体构成，紫外光荧光体由A荧光体或B荧光体单独构成或组合而成；A荧光体的化学表达式为M 1-x-y·Al 11O 19：Cd xR y，B荧光体的化学表达式为M 1-x-y-zLa yMg z·B 3O 7：Pb x。形成具有发光效率高、光衰小、化学稳定性好等特点并模拟生物光的荧光光源，光源材料能够有效预防、治疗血脂异常以及由此而引发的相关疾病，基于此荧光光源所形成的调血脂仪器具有结构简单紧凑、使用方便、治疗效果显著的特点。

Description

[根据细则37.2由ISA制定的发明名称]　调血脂仪器及其使用的光源材料 技术领域
本发明涉及医疗技术领域，尤其是一种调血脂仪器及其使用的光源材料。
背景技术
在我国，由于人民的生活水平的明显提高、饮食习惯发生改变等原因，血脂异常的发生率很高，而且呈逐渐上升的趋势。周知，血脂异常属于一类较为常见的疾病，是人体内脂蛋白的代谢异常，主要包括总胆固醇和低密度脂蛋白胆固醇、甘油三酯升高和/或高密度脂蛋白降低等，其是导致动脉粥样硬化的重要因素之一，也是冠心病和缺血性脑卒中的独立危险因素。
因此，提供一种能够有效预防、治疗血脂异常及因血脂异常而引起相关疾病的设备，对广大医患人员具有很现实的意义。
发明内容
针对上述现有技术存在的不足，本发明的其中一个目的在于一种发光效率高、光衰小、化学稳定性强的光源材料；本发明的另一个目的在于提供一种结构简单紧凑、以光源材料为基础、能够有效预防、治疗血脂异常及因血脂异常而引起相关疾病的调脂仪。
为了实现上述目的，本发明采用如下技术方案：
一种光源材料，它包括荧光粉，按质量百分比，所述荧光粉由0.1-100.0的紫外光荧光体和0.0-99.9的可见光荧光体构成，其中，紫外光荧光体由A荧光体构成或由B荧光体构成或由A荧光体和B荧光体组合而成；
所述A荧光体的化学表达式为M1-x-y·Al11O19：CdxRy，所述B荧光体的化学表达式为M1-x-y-zLayMgz·B3O7：Pbx；其中，0.001≤x≤0.1、0.001≤y≤0.5、0.001≤z≤0.5、M为钡、钙、镁、锶、锌中的一种元素或多种元素的组合,R为 铋、钪、钇、镨、钐、铈、镝、钬、钕、铒、镱、镥中的一种元素或多种元素的组合。
优选地，所述A荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围为307±5nm。
优选地，所述B荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围为297±5nm。
一种调血脂仪器，它包括一立式机体，所述立式机体的底面向前延伸后形成有一踏座，所述立式机体的顶部装设有一与踏座并行分布的量子发生器，所述立式机体的前侧壁的中部、位于踏座与量子发生器的之间装设有一发射光谱的峰值范围在297-450nm之间的能量探测器，所述量子发生器包括辅助光源和荧光光源，所述荧光光源的光源材料采用上述的一种光源材料，所述辅助光源为日光灯、LED灯、半导体散焦激光灯中的一种或者多种任意组合。
优选地，所述辅助光源的发射光谱的范围为610nm-800nm。
优选地，所述荧光光源还包括外形呈直管形、弯管形、圆球形或椭球形的灯壳，所述灯壳由高硼硅玻璃制成。
优选地，所述立式机体包括立柱部以及装设于立柱部的后侧壁的下方的集控台，所述踏座形成于立柱部的底部前端，所述能量探测器装设于立柱部的前侧壁的中部，所述立柱部内装设有一受集控台控制并与量子发生器相连的升降驱动器，所述升降驱动器驱动量子发生器相对于立柱部作上下进给运动，所述能量探测器和量子发生器分别与集控台电连接并受控于集控台。
优选地，所述踏座的底面上装设有两个对称分布的前脚轮，所述集控台的底面上装设有两个对称分布的后脚轮以及一位于两个后脚轮之间的地刹器，所述集控台还形成有一推手。
由于采用了上述方案，本发明可形成具有发光效率高、光衰小、化学稳定性好等特点并模拟生物光的荧光光源，荧光光源可采用光照射的方式并利用生物医学及光子学的原理对人体进行照射，光源材料能够发射可见光、散焦激光及UV-B段的健康波形；而基于此光源材料所形成的调血脂仪器所释放的光量 子被血脂选择性吸收后，促进了人体的血脂发生生化反应，利用人体固有的血脂代谢途径，胆固醇、甘油三酯等被人体代谢，因而能够有效预防、治疗血脂异常以及由此而引发的相关疾病；并且调血脂仪器具有结构简单紧凑、使用方便、治疗效果显著的特点。
附图说明
图1为本发明实施例的整体结构示意图(一)；
图2为本发明实施例的整体结构示意图(二)；
图3为本发明实施例的结构分解示意图；
图4为本发明实施例的量子发生器的结构示意图。
具体实施方式
以下结合附图对本发明的实施例进行详细说明，但是本发明可以由权利要求限定和覆盖的多种不同方式实施。
本发明实施例的一种荧光光源，它包括荧光粉，按质量百分比，所述荧光粉由0.1-100.0的紫外光荧光体和0.0-99.9的可见光荧光体构成，其中，紫外光荧光体由A荧光体构成或由B荧光体构成或由A荧光体和B荧光体组合而成；A荧光体的化学表达式为M1-x-y·Al11O19：CdxRy，B荧光体的化学表达式为M1-x-y-zLayMgz·B3O7：Pbx；其中，0.001≤x≤0.1、0.001≤y≤0.5、0.001≤z≤0.5、M为锶(Sr)、钙(Ca)、钡(Ba)、锌(Zn)中的一种元素或多种元素的组合,R为铋(Bi)、钪(Sc)、钇(Y)、镨(Pr)、钐(Sm)、铈(Ce)、镝(Dy)、钬(Ho)、钕(Nd)、铒(Er)、镱(Yb)、镥(Lu)中的一种元素或多种元素的组合。由此，通过对紫外光荧光体的组分的改进并将紫外光与可见光结合一体，可形成具有发光效率高、光衰小、化学稳定性好等特点的荧光光源，其可采用光照射的方式并利用生物医学及光子学的原理对人体进行照射，由于光源材料能够发射可见光、散焦激光及UV-B段的健康波形，因而能够有效预防、治疗血脂异常以及由此而 引发的相关疾病，对增强人体疾病的抵抗能力及维持人体健康起到至关重要的作用。
为保证荧光光源能够发射有效的健康波形，本实施例的A荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围优选为307±5nm。B荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围则优选为297±5nm。
基于上述荧光光源，如图1至图4所示，本发明还提供了一种调血脂仪器，它包括一立式机体，在立式机体的底面向前延伸后形成有一踏座1，在立式机体的顶部装设有一与踏座1并行分布的量子发生器2，在立式机体的前侧壁的中部、位于踏座1与量子发生器2的之间装设有一发射光谱的峰值范围在297-450nm之间的能量探测器3，量子发生器2包括辅助光源a和荧光光源b，其中，荧光光源b的光源材料采用上述的一种光源材料，而辅助光源a则为根据具体情况选用日光灯、LED灯(其发射光谱峰值为297-800nm)、半导体散焦激光灯(其发射峰值为650nm的散焦激光)中的一种或者多种任意组合。从而利用荧光光源b以及辅助光源a构成调血脂仪器的生物光源(即量子发生器2)，患者通过踏座1靠立式机体站立于仪器上后，由量子发生器2对人体进行照射，由量子发生器2所产生的光量子被血脂对应性吸收，促进人体的血脂发生生化反应，利用人体固有的代谢血脂途径，胆固醇、甘油三酯等被人体代谢，以此达到降血脂、降血压、降血粘、提高红细胞携氧能力、促进血液循环、改善微循环、提高机体免疫力、增强肺活量、调节生理功能等目的；同时利用能量探测器3可实时监测照射于人体上的光照能量，便于对光照强度进行实时调整。
为保证调血脂仪器的光照射效果，本实施例的辅助光源a的发射光谱的范围优选为610nm-800nm。
为优化整个调血脂仪器的结构，本实施例的荧光光源b还包括外形呈直管形、弯管形、圆球形或椭球形的灯壳(图中未示出)，灯壳则由高硼硅玻璃制 成，以此，利用高硼玻璃来透过UV-B段光线和可见光并同时对UV-C段光线进行截止，保证健康波形的透光性。
为最大限度地简化整个调血脂仪器的结构，提高其使用的便利性，本实施例的立式机体包括立柱部4以及装设于立柱部4的后侧壁的下方的集控台5(其主要由外壳体、封装于外壳体内的驱动板以及嵌装于外壳体上的触控操作屏构成)，踏座1形成于立柱部4的底部前端，能量探测器3装设于立柱部4的前侧壁的中部，同时在立柱部4内装设有一受集控台5控制并与量子发生器2相连的升降驱动器6(其主要由液压驱动器以及导向轨等器件构成)，升降驱动器6驱动量子发生器2相对于立柱部4作上下进给运动，而能量探测器3和量子发生器2分别与集控台5电连接并受控于集控台5。如此，可利用集控台5作为整个仪器的操作终端，实现对仪器功能的控制，而通过升降驱动器6所提供的动力，可根据患者的个体情况对量子发生器2进行位置调整，以为患者提供足够的站立空间，便于量子发生器2对人体部位进行照射。
为增强仪器的可操作性以及移动性，在踏座1的底面上装设有两个对称分布的前脚轮7，在集控台5的底面上装设有两个对称分布的后脚轮8以及一位于两个后脚轮8之间的地刹器9(其可使仪器升高，保证相应的脚轮脱离底面，从而防止仪器随意移动)，同时在集控台5还形成有一推手10，便于操作人员推动仪器。
为保证调血脂仪器对相关疾病的预防及治疗效果，本发明实施例的一种调血脂仪器可采用如下使用方法，该方法包括以下步骤：
S1、根据患者的实际病理情况，利用控制组件确定量子发生器2的照射时间；
S2、当人体站立于仪器上后，利用量子发生器2对人体进行照射；其中，量子发生器2的出光功率(即总辐照剂量)为每天累积不超过10μw/cm2/min～200μw/cm2/min，移动模块的出光功率(即总辐照剂量)为每天累积不超过10μw/cm2/min～200μw/cm2/min。
以上所述仅为本发明的优选实施例，并非因此限制本发明的专利范围，凡是利用本发明说明书及附图内容所作的等效结构或等效流程变换，或直接或间接运用在其他相关的技术领域，均同理包括在本发明的专利保护范围内。

Claims (8)

  1. 一种光源材料，它包括荧光粉，其特征在于：按质量百分比，所述荧光粉由0.1-100.0的紫外光荧光体和0.0-99.9的可见光荧光体构成，其中，紫外光荧光体由A荧光体构成或由B荧光体构成或由A荧光体和B荧光体组合而成；
    所述A荧光体的化学表达式为M1-x-y·Al11O19：CdxRy，所述B荧光体的化学表达式为M1-x-y-zLayMgz·B3O7：Pbx；其中，0.001≤x≤0.1、0.001≤y≤0.5、0.001≤z≤0.5、M为钡、钙、镁、锶、锌中的一种元素或多种元素的组合，R为铋、钪、钇、镨、钐、铈、镝、钬、钕、铒、镱、镥中的一种元素或多种元素的组合。
  2. 如权利要求1所述的一种光源材料，其特征在于：所述A荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围为307±5nm。
  3. 如权利要求1所述的一种光源材料，其特征在于：所述B荧光体在波长为254nm的紫外光的激发下发射光谱的峰值范围为297±5nm。
  4. 一种调血脂仪器，其特征在于：它包括一立式机体，所述立式机体的底面向前延伸后形成有一踏座，所述立式机体的顶部装设有一与踏座并行分布的量子发生器，所述立式机体的前侧壁的中部、位于踏座与量子发生器的之间装设有一发射光谱的峰值范围在297-450nm之间的能量探测器，所述量子发生器包括辅助光源和荧光光源，所述荧光光源的光源材料采用权利要求1-3中任一项所述的一种光源材料，所述辅助光源为日光灯、LED灯、半导体散焦激光灯中的一种或者多种任意组合。
  5. 如权利要求4所述的一种调血脂仪器，其特征在于：所述辅助光源的发射光谱的范围为610nm-800nm。
  6. 如权利要求4所述的一种调血脂仪器，其特征在于：所述荧光光源还包括外形呈直管形、弯管形、圆球形或椭球形的灯壳，所述灯壳由高硼硅玻璃制成。
  7. 如权利要求4-6中任一项所述的一种调血脂仪器，其特征在于：所述立式机体包括立柱部以及装设于立柱部的后侧壁的下方的集控台，所述踏座形成于立柱部的底部前端，所述能量探测器装设于立柱部的前侧壁的中部，所述立柱部内装设有一受集控台控制并与量子发生器相连的升降驱动器，所述升降驱动器驱动量子发生器相对于立柱部作上下进给运动，所述能量探测器和量子发生器分别与集控台电连接并受控于集控台。
  8. 如权利要求7所述的一种调血脂仪器，其特征在于：所述踏座的底面上装设有两个对称分布的前脚轮，所述集控台的底面上装设有两个对称分布的后脚轮以及一位于两个后脚轮之间的地刹器，所述集控台还形成有一推手。
PCT/CN2016/097274 2016-06-03 2016-08-30 调血脂仪器及其使用的光源材料 WO2017206380A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610389566.7 2016-06-03
CN201610389566.7A CN105907394B (zh) 2016-06-03 2016-06-03 一种调血脂仪器及其使用的光源材料

Publications (1)

Publication Number Publication Date
WO2017206380A1 true WO2017206380A1 (zh) 2017-12-07

Family

ID=56743265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/097274 WO2017206380A1 (zh) 2016-06-03 2016-08-30 调血脂仪器及其使用的光源材料

Country Status (2)

Country Link
CN (1) CN105907394B (zh)
WO (1) WO2017206380A1 (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326907A (zh) * 2000-05-09 2001-12-19 松下电器产业株式会社 透光性烧结体和用它制成的发光管和放电灯
CN101045177A (zh) * 2006-03-31 2007-10-03 优志旺电机株式会社 光线治疗仪
CN101508894A (zh) * 2009-03-20 2009-08-19 孙德春 一种碱土金属硼酸盐荧光体及其制备方法和应用
US20090268429A1 (en) * 2005-11-10 2009-10-29 Nozomu Hashimoto Fluorescent lamp, manufacturing method therefor, lighting device using the fluorescent lamp, and display device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003124526A (ja) * 2001-10-11 2003-04-25 Taiwan Lite On Electronics Inc 白色光光源製造方法
CN101546688A (zh) * 2009-03-20 2009-09-30 孙德春 一种畜禽养殖用荧光灯
DE102009050542A1 (de) * 2009-10-23 2011-04-28 Merck Patent Gmbh Sm-aktivierte Aluminat- und Borat-Leuchtstoffe
CN101804247B (zh) * 2010-02-08 2012-05-09 孙德春 一种动物疾病预防保健照明装置
CN101880531B (zh) * 2010-06-25 2013-05-01 孙德春 稀土卤磷酸盐荧光体与其制备方法和应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326907A (zh) * 2000-05-09 2001-12-19 松下电器产业株式会社 透光性烧结体和用它制成的发光管和放电灯
US20090268429A1 (en) * 2005-11-10 2009-10-29 Nozomu Hashimoto Fluorescent lamp, manufacturing method therefor, lighting device using the fluorescent lamp, and display device
CN101045177A (zh) * 2006-03-31 2007-10-03 优志旺电机株式会社 光线治疗仪
CN101508894A (zh) * 2009-03-20 2009-08-19 孙德春 一种碱土金属硼酸盐荧光体及其制备方法和应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG XIURONG ET AL.: "Laser Properties of Lamp Pumped La1-xMgNdxAl11O19 Crystals", CHINESE JOURNAL OF LASERS, vol. 19, no. 7, 29 July 1992 (1992-07-29), pages 496 - 498 *

Also Published As

Publication number Publication date
CN105907394B (zh) 2019-01-15
CN105907394A (zh) 2016-08-31

Similar Documents

Publication Publication Date Title
US6866678B2 (en) Phototherapeutic treatment methods and apparatus
DE69434525T2 (de) Apparat zur photodynamischen Therapie
US20150025602A1 (en) Treatment apparatus and use thereof for treating psoriasis
EP2856020A1 (de) Vorrichtung zum verwenden in einem medizinischen behandlungsraum
CA2444891A1 (en) Photodynamic stimulation device and methods
KR20150120425A (ko) 광선 요법용 양자점 발광 다이오드
WO2003077996A2 (en) A device and method for treatment of external surfaces of a body utilizing a light-emitting container
RU112631U1 (ru) Устройство фотодинамического воздействия на ткани живого организма
WO2016208244A1 (ja) 光線力学的治療用光照射装置および光照射方法
WO2011058048A1 (de) Dermatologisches behandlungsgerät
WO2017206380A1 (zh) 调血脂仪器及其使用的光源材料
WO2017206379A1 (zh) 痛风治疗仪及其使用的光源材料
KR20160045856A (ko) 광선요법에서의 확산 안료
WO2017206381A1 (zh) 糖尿病治疗仪及其使用的光源材料
Lin et al. 3D upconversion barcodes for combinatory wireless neuromodulation in behaving animals
WO2013172859A1 (en) Apparatus for maintaining treatment of peripheral neuropathy
CN2675164Y (zh) 光子痤疮治疗仪
CN211024845U (zh) 激光疲劳照射器
CN202376642U (zh) 光学量子仪
KR20210107869A (ko) 광 조사 장치
RU96007U1 (ru) Устройство для облучения поверхности тела оптическим излучением при ожогах
CN205683412U (zh) 一种复合治疗仪
CN211024846U (zh) 激光疲劳治疗床
Edge et al. Biophotonic Therapy Induced Photobiomodulation
CN206715053U (zh) 一种基于光动力的治疗装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16903762

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16903762

Country of ref document: EP

Kind code of ref document: A1